Anupam Rasayan India Limited
NSE: ANURASINE930P01018·ChemicalsSmallcap 250·www.anupamrasayan.com ↗·Mcap ₹13,581 Cr·Listed 2021
₹1,192.40▲ ₹15.20  (1.29%)
52W: ₹1,045 – ₹1,415 · Vol: 1.7L shares · Close 25 Sept
Set Alert

Your Screens

the ones you keep on the screener

Ready-made Screens It Passes

each filter against ANURAS's own figure
ANURAS passes none of the ready-made screens today.

One or two filters away

which filter, and by how much
476 companies pass it today · see them →
✓
revenue growth at least 15%51.8%
✗
profit growth at least 15%14.6%
92 companies pass it today · see them →
✓
made a profit over the last four quarters₹225 Cr
✗
dividend yield at least 3%0.1%
249 companies pass it today · see them →
✓
made a profit over the last four quarters₹225 Cr
✗
P/E at most 1560.4
✓
market cap at least ₹1,000 Cr₹13,581 Cr
262 companies pass it today · see them →
✓
made a profit over the last four quarters₹225 Cr
✗
P/B at most 14.1
123 companies pass it today · see them →
✗
within 10% of its 52-week high41% of the way up
✓
market cap at least ₹5,000 Cr₹13,581 Cr
135 companies pass it today · see them →
✗
within 10% of its 52-week low41% of the way up
✓
market cap at least ₹5,000 Cr₹13,581 Cr
59 companies pass it today · see them →
✗
top 100 by market cap#501
✓
made a profit over the last four quarters₹225 Cr
✗
ROE at least 15%6.7%

3 other ready-made screens it misses on every filter or on more than two. All screens →

ANURAS Figuresrebuilt 26 Sept
Market cap₹13,581 Cr
Rank by market cap#501
P/E60.4
P/B4.1
ROE6.7%
Debt to equity0.54
Revenue growth51.8%
Profit growth14.6%
Net margin8.9%
Dividend yield0.1%
Place in its 52-week range41% of the way up
Below its 52-week high13.3%
Daily turnover₹60 Cr

The last four quarters of filings, consolidated where the company files it, and our end-of-day closes. These are the numbers every filter on this page is held against.

Write Your Own
A screen is a line of English: “debt free with roe above 20%”. Keep one, and it is run again every night; this page then shows whether ANURAS passes it.
Open the screener →